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Abstract
Background: Angiopoietin-1 (ANGPT1) and angiopoietin-2 (ANGPT2) are angiogenesis factors that modulate endothelial
cell differentiation, survival and stability. Recent studies have suggested that skeletal muscle precursor cells constitutively
express ANGPT1 and adhere to recombinant ANGPT1 and ANGPT2 proteins. It remains unclear whether or not they also
express ANGPT2, or if ANGPT2 regulates the myogenesis program of muscle precursors. In this study, ANGPT2 regulatory
factors and the effects of ANGPT2 on proliferation, migration, differentiation and survival were identified in cultured primary
skeletal myoblasts. The cellular networks involved in the actions of ANGPT2 on skeletal muscle cells were also analyzed.
Methodology/Principal Findings: Primary skeletal myoblasts were isolated from human and mouse muscles. Skeletal
myoblast survival, proliferation, migration and differentiation were measured in-vitro in response to recombinant ANGPT2
protein and to enhanced ANGPT2 expression delivered with adenoviruses. Real-time PCR and ELISA measurements revealed
the presence of constitutive ANGPT2 expression in these cells. This expression increased significantly during myoblast
differentiation into myotubes. In human myoblasts, ANGPT2 expression was induced by H2O2, but not by TNFa, IL1b or IL6.
ANGPT2 significantly enhanced myoblast differentiation and survival, but had no influence on proliferation or migration.
ANGPT2-induced survival was mediated through activation of the ERK1/2 and PI-3 kinase/AKT pathways. Microarray analysis
revealed that ANGPT2 upregulates genes involved in the regulation of cell survival, protein synthesis, glucose uptake and
free fatty oxidation.
Conclusion/Significance: Skeletal muscle precursors constitutively express ANGPT2 and this expression is upregulated
during differentiation into myotubes. Reactive oxygen species exert a strong stimulatory influence on muscle ANGPT2
expression while pro-inflammatory cytokines do not. ANGPT2 promotes skeletal myoblast survival and differentiation. These
results suggest that muscle-derived ANGPT2 production may play a positive role in skeletal muscle fiber repair.
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Introduction
Through their specific effects on precursor cell survival and
adhesion, angiopoietins are recognized not only as angiogenesis
regulators but also as important modulators of skeletal muscle
function [1]. Angiopoietins are ligands for TIE2 receptors.
Angiopoietin-1 (ANGPT1) is the main ligand that is produced,
mainly by cardiac skeletal and smooth muscle cells, adventitial
cells, and, to a lesser extent, endothelial cells [2]. In comparison,
angiopoietin-2 (ANGPT2) is expressed in the endothelium, tumor
cells, macrophages and muscle cells [3–6]. In endothelial cells,
ANGPT2 binds to TIE2 receptors with similar affinity to that of
angiopoietin 1 (ANGPT1). However, while ANGPT1 is a strong
agonist of TIE2 receptors, the ability of ANGPT2 to activate TIE2
receptors is highly dependent on the cell type and context [2].
Most investigators agree that ANGPT1 and TIE2 receptors
play critical roles in early vascular development and angiogenesis.
The involvement of ANGPT2 is less clear, particularly in regard to
embryonic vascular and lymphatic formation. The observation
that transgenic overexpression of ANGPT2 elicits similar pheno-
types to those seen in TIE2- and ANPGT1-deficient mice has led
to the conclusion that ANGPT2 antagonizes ANGPT1 during
vascular development [5]. However, a recent study using
ANGPT2-deficient mice has revealed that ANGPT2 plays a
crucial role in lymphatic vascular development, as indicated by
post-natal lethality, the development of chylous ascites and the
appearance of lymphatic vascular defects [7].
In the vascular system, ANGPT2 expressions are significantly
induced by pro-inflammatory mediators. Indeed, exposure to
TNFa, thrombin or angiotensin II upregulates ANGPT2 expres-
sion in cultured endothelial cells [8,9]. It has also been
documented that plasma ANGPT2 levels are elevated in patients
with severe sepsis and in children with septic shock, and injection
of ANGPT2 protein in vivo elicits significant increases in edema
formation in the mouse paw [10–12]. These findings suggest a
strong link between inflammatory mediators, the development of
oxidative stress (important contributor to tissue injury in sepsis)
and ANGPT2 expression in the vascular system.
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ANGPT2 expression, little is known about the presence and
expression of ANGPT2 in non-vascular cells, including in skeletal
muscles. For example, it is not clear which factors regulate
ANGPT2 expression in these muscles. The first objective of this
study, therefore, is to document ANPGT2 expression in skeletal
muscle cells and to evaluate the roles of pro-inflammatory
cytokines and reactive oxygen species (ROS) on skeletal muscle-
derived ANPGT2 production. Our main hypotheses are that
skeletal muscle cells constitutively express ANGPT2 and that
muscle-derived ANGPT2 production is significantly induced by
pro-inflammatory cytokines and ROS. This hypothesis is based on
the strong relationships between induction of ANGPT2 produc-
tion and elevated pro-inflammatory cytokine levels in the vascular
system and on the observation that ROS trigger the release of
angiogenesis factors in skeletal muscle cells [10–13].
Skeletal muscle precursor cells are muscle-specific progenitor
cells that play a critical role in skeletal muscle regeneration in
response to injury. They proliferate, migrate, fuse to each other
then differentiate to form myofibers, leading to complete
regeneration of muscle fibers. Many angiogenic growth factors,
such as VEGF, FGFs, and insulin-like growth factor-1 (IGF1), act
in an autocrine fashion to promote precursor cell myogenesis by
enhancing proliferation, migration, differentiation and survival of
these cells [14–16]. Although signaling and vascular effects of
endothelial cell angiopoietins are well characterized, there is as yet
a paucity of information regarding the influence of angiopoietins
on the myogenesis program of skeletal muscle precursor cells. The
second objective of this study, therefore, is to evaluate functional
effects of ANGPT2 on skeletal muscle precursor cell myogenesis,
including proliferation, migration, differentiation and survival, and
the mechanisms through which ANGPT2 influence these
processes. On the basis of preliminary experiments, we hypoth-
esize that ANGPT2 plays positive roles in promoting both
differentiation and survival of muscle cells and that these effects
are mediated through selective activation of specific cellular
signaling pathways that include protein kinase B (AKT) and the
ERK1/2 members of the mitogen-activated protein kinases
(MAPKs).
Materials and Methods
ANGPT2 Expression in skeletal and endothelial cells
While ANGPT2 is known to be produced by endothelial cells,
production of this factor by primary skeletal precursor cells is less
clear. Hence, we measured the levels of ANGPT2 production in
both, human and murine primary skeletal precursor cells. Primary
human muscle precursor cells (human myoblasts) immortalized by
expression of the E6E7 early region from human papillomavirus
type 16, were generously provided by Dr. E. Shoubridge (McGill
University, Montre ´al, QC), and cultured in SkBM culture medium
(SkBMH Bullet Kit, Cambrex, East Rutherford, NJ) supplemented
with 15% inactivated fetal bovine serum (FBS)[17]. Cells were
collected and total RNA was extracted using a GenElute
TM
Mammalian Total RNA Miniprep Kit (Sigma-Aldrich, Oakville,
ON). Quantification and purity of total RNA was assessed by
A260/A280 absorption. The levels of ANGPT2 mRNA and 18S
(control gene) were detected using TaqMan real-time PCR assays
(Applied Biosystems Inc.). RNA (2 mg) was reverse- transcribed
using Superscript IIH Reverse Transcriptase Kits and random
primers (Invitrogen Inc.). Reactions were incubated at 42uC for
50 min and at 90uC for 5 min. Real-time PCR was performed
using a Prism 7000 Sequence Detection System (Applied
Biosystems, Foster City, CA). To quantify expressions of ANGPT2
and 18S (endogenous control), TaqManH Gene Expression Assays
(Applied Biosystem Inc.) specific to these genes were used. The
thermal profile was as follows: 95uC for 10 min and 40 cycles of
95uC for 15 sec, 57uC for 30 sec, and 72uC for 33 sec. All real-
time PCR experiments were performed in triplicate. A melt
analysis for each PCR experiment was performed to assess primer-
dimer formation or contamination. To determine the absolute
copy numbers of ANGPT2 and 18S mRNA transcripts, standard
curves that related the cycle threshold (CT) values of these genes to
the copy numbers were established, as described in our recent
study [3]. Copy numbers of ANGPT2 were then normalized per
copies of 18S. In addition, relative quantification of ANGPT2
mRNA levels compared to those of control condition was
determined using the threshold cycle (DDCT) method.
To evaluate the changes in ANGPT2 mRNA in human
myoblasts during differentiation to myotubes, human skeletal
myoblasts were induced to differentiate into myotubes by growing
confluent myoblasts (90% confluent) in Dulbecco’s modified
Eagle’s medium (DMEM) (Invitrogen Inc., Carlsbad, CA)
supplemented with 2% inactivated horse serum (HS) for 7 days.
Cells were collected at days 0 (myoblasts), 1, 3, 5 and 7 and total
RNA was extracted as described above. ANGPT2 mRNA and
18S levels during differentiation were detected using real-time
PCR as described above.
All animal experiments were approved by McGill University
Animal Care Committee (protocol# 3870). To isolate primary
murine skeletal precursor cells, tibialis anterior muscle strips were
extracted from 6-week-old C57/BL6 mice, digested with collage-
nase (0.2% at 37uC for 60 min) and then triturated to break
muscle tissues into single fibers. Individual fibers were washed in
(DMEM) and phosphate-buffered saline, transferred into Matri-
gelH-coated (1 mg/ml in DMEM) 6-well plates and maintained in
DMEM supplemented with 1% penicillin/streptomycin and 0.2%
amphotericin B, 10% HS and 0.5% chick embryo extract (MP
Biomedicals, Aurora, OH) for 4 days, which allowed myoblasts to
attach to the substratum. Cells were then collected and total RNA
was extracted as described. ANGPT2 mRNA levels were detected
using real-time PCR and murine TaqmanH ANGPT2 assays
(Applied Biosystems). ANGPT2 mRNA expression in these cells
was expressed as copies normalized for 18S copies.
Regulation of ANGPT2 expression in human myoblasts
by cytokines and H2O2
To assess whether muscle-derived ANGPT2 production is
under the control of inflammatory cytokines and oxidagive stress,
we measured the effects of TNFa, IL1b, IL6 and hydrogen
peroxide (H2O2, mediator of oxidative stress) on ANGPT-2
expression in muscle cells. Human skeletal myoblasts were plated
into 12-well plates (10
5 cells per well) and maintained for 24 h in
SkBM culture medium containing 5% FBS. Cells were then
stimulated with recombinant human IL-1b (20 ng/ml), TNFa
(40 ng/ml), IL6 (50 ng/ml), mixture of the three cytokines, H2O2
(0.5 mM), or a control solution of phosphate-buffered saline (PBS).
Cells were collected 24 h later and prepared for total RNA
extraction and ANGPT2 mRNA expression using real-time PCR
(see above). Relative quantification of ANGPT2 mRNA levels in
cells treated with cytokines or H2O2 compared to control cells was
determined using the threshold cycle method. In additional
experiments, human myoblasts were stimulated for 24 h with
TNFa (40 ng/ml) or H2O2 (0.5 mM) or PBS. Media and cell
lysates were collected ANGPT2 protein levels in the media were
measured with ELISA (Angiopoietin-2 Quantikine ELISA, R& D
Systems Inc.) and normalized for cell lysate protein levels.
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vein endothelial cells (HUVECs)
To compare the influence of ANGPT2 on survival of skeletal
precursor cells to that elicited in endothelial cells, we studied
HUVECs which were cultured in endothelial basal medium
(MCDB131) supplemented with 20% fetal bovine serum (FBS),
endothelial cell growth supplement, 2 mM glutamine, heparin,
penicillin (100 units/ml), streptomycin (100 mg/ml) and ampho-
tericin B (0.25 mg/ml). HUVECs were plated into 12-well plates
(10
5 cells per well) and maintained for 24 h in endothelial cell
basal medium supplemented with 2% FBS containing PBS
(control), TNFa (40 ng/ml) or H2O2 (0.5 mM). Cells and media
were then collected and ANGPT2 protein levels in the media were
measured with ELISA as described above.
Regulation of myoblast myogenesis by ANGPT2
Myoblast proliferation. The effects of ANGPT2 on
myoblast cell proliferation were measured by seeding human
myoblasts (1610
5 cells) into 6-well culture plates for 24 h in SkBM
culture medium containing 15% FBS. Culture medium was then
replaced with SkBM culture medium containing 5% FBS and
either PBS or 150, 300 and 600 ng/ml of recombinant human
ANGPT2. These concentrations have been extensively employed
to evaluate the biological responses to ANGPT2 in cultured cells.
Culture medium containing PBS or ANGPT2 protein was
replenished every 24 h. After 72 h of exposure, cells were then
exposed to 0.5% trypsin-EDTA, stained with trypan blue and
viable cells were counted by hematocytometer.
Myoblast migration. Regulation of skeletal myoblast
migration by ANGPT2 was assessed using wound healing assay.
Human myoblasts (1610
5 cells) were seeded into 6-well culture
plates and maintained for 24 h in SkBM culture medium
containing 15% FBS. Cells were then carefully wounded using a
200-ml pipette tip, as previously described [18]. Cellular debris was
removed by washing with phosphate-buffered saline (PBS). After
wounding, culture medium was replaced with SkBM containing
5% FBS and either PBS (control) or 600 ng/ml recombinant
human ANGPT2. Wounds were photographed immediately after
wounding (time=0) and 12 and 18 h later using an Olympus
inverted microscope (Model X70) equipped with phase-contact
lenses. Migration was evaluated by measuring the reduction in the
diameter of the wound after migration of the cells into the cell-free
zone [3726}. For each condition, three wells of a given 6-well plate
were used, and the procedure was performed in triplicate.
Intracellular signaling by ANGPT2 in satellite cells. Several
reports have confirmed that the PI-3 kinase/AKT and the Erk1/2
pathways are important in promoting many of the biological effects of
angiopoietins in endothelial cells [19,20]. To evaluate whether these
two pathways are activated by ANGPT2 in skeletal muscle precursors,
human skeletal myoblasts were maintained in SkBM culture medium
containing 5%FBS for 12 h. Cells were then stimulated with PBS
(control) or recombinant human ANGPT2 (300 ng/ml) for 5, 15, 30
and 60 min. The medium was then removed and adherent cells were
washed twice with PBS and lysed in basic lysis buffer (see below). In
addition, human myoblasts were stimulated for 15 min with PBS or
50, 150, 300 or 600 ng/ml of ANGPT2. Cells were lysed in basic lysis
buffer containing HEPES (50 mM), NaCl (150 mM), NaF (100 mM),
EDTA (5 mM) and protease inhibitors (aprotinin 5 mg/ml, leupeptin
2 mg/ml and PMSF 100 mM). Cell debris and nuclei were separed by
centrifugation at 14,000 g for 5 min at 4uC. Supernatants were then
boiled for 5 min then loaded onto tris-glycine SDS-PAGE. Proteins
were electrophoretically transferred onto polyvinylidene difluoride
membranes, blocked for 1 h with 5% nonfat dry milk, and incubated
overnight at 4uC with primary antibodies to phospho-AKT (Thr
308),
total AKT, phospho-Erk1/2 (Thr
202/Tyr
204) and total Erk1/2 (Cell
Signaling Inc.). Proteins were detected with horseradish peroxidase–
conjugated secondary antibodies and ECL reagents (Chemicon).
Loading of equal amounts of protein was confirmed by stripping the
membranes and re-probing with anti-tubulin antibody (Sigma-
Aldrich). Blots were scanned with an imaging densitometer, and
optical densities of protein bands were quantified with ImagePro
software (Media Cybernetics, Carlsba d ,C A ) .P r e d e t e r m i n e dm o l e c u l a r
weight standards were used as markers. Protein concentrations were
measured by the Bradford method, with BSA as a standard.
Myoblast survival and apoptosis. To evaluate the
influence of ANGPT2 on skeletal muscle precursor cell survival,
human skeletal myoblasts (25610
3 cells) were seeded into 96-well
plates and maintained for 12 h in SkBM culture medium
containing 15%FBS. Culture medium was then replaced with
SkBM culture medium (0%FBS) containing either PBS or 300 ng/
ml recombinant human ANGPT2. Cell cytotoxicity and caspase3/
7 activity were measured 36 h later using CytoTox-Fluor
TM
Cytotoxicity Assay and Caspase-Glo
TM 3/7 Assay, respectively,
according to the manfacturer’s instructions (Promega Inc.
Madison, WI). The involvement of the PI-3 kinase/AKT and
Erk1/2 pathways in the regulation of muscle cell survival and
caspase 3/7 activity, we incubated human skeletal myoblasts in
SkBM culture medium (0%FBS) containing either PBS (control
condition) or 300 ng/ml of recombinant human ANGPT2 in the
presence and absence of 2 mM of PD184352 (Erk1/2 inhibitor),
50 nM of wortmannin (PI-3 kinase inhibitor) and 1 mM of API-2
(Tricirbine, AKT inhibitor). Cell death (cytotoxicity) and
caspase3/7 activity were measured 36 h later using CytoTox-
Fluor
TM Cytotoxicity Assay and Caspase-Glo
TM 3/7 Assay,
respectively.
Myoblast differentiation. We evaluated the influence of
ANGPT2 on human myoblast differentiation by over-expressing
ANGPT2 in human skeletal myoblasts using adenoviruses. The
choice of using adenoviruses to deliver ANGPT2 was aimed at
achieving sustained endogenous elevation of ANGPT2 production
over several days required for full differentiation of skeletal
myoblasts into myotubes. Recombinant adenoviruses expressing
ANGPT2 (Ad-ANGPT2) were constructed using the Adeno-
Quest
TM system (Quantum Biotechnology Inc., Montreal,
Canada). Full-length cDNA encoding human ANGPT2 was
cloned into shuttle vector pQBI-AdCMV5GFP [21]. Sub-
confluent human myoblasts were maintained for 6 h in SkBM
culture medium containing 250 MOI (multiplicity of infection) of
Ad-ANGPT2 or Ad-GFP (control cells). Cells were then washed
and maintained for 48 h in SkBM culture medium containing
15% FBS to reach full confluence. After this recovery period, the
cells were collected (day 0, myoblast phase) for RNA extraction
and also differentiated into myotubesby replacing the medium
with Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen
Inc., Carlsbad, CA) supplemented with 2% inactivated horse
serum (HS). Differentiating cells were collected at 1, 3, 5 and 7
days of incubation with the differentiation medium. Total RNA
was extracted as described above. Total RNA (2 mg) was then
reverse transcribed using Superscript IIH Reverse Transcriptase
Kits and random primers (Invitrogen). Reactions were incubated
at 42uC for 50 min and at 90uC for 5 min. Expression of
myogenic transcription factors MyoD and Myogenin as well as
muscle-specific Myosin Heavy Chain and Creatine Kinase mRNA
levels as well as that of 18S levels during differentiation were
detected using real-time PCR as described above. Primers
designed to amplify these transcripts are listed in Supporting
Information S1. Real-time PCR was performed using a Prism
7000 Sequence Detection System (Applied Biosystems, Foster
Angiopoietin-2 and Skeletal Myogenesis
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transcripts of a specific gene and 18S mRNA transcripts, standard
curves that related the cycle threshold (CT) values of these genes to
the copy numbers were established, as described in our recent
study [3]. Copy numbers of these genes were then calculated as
described above and normalized per copies of 18S.
Mechanisms of ANGPT2 action in skeletal myoblasts
To investigate the mechanisms through which ANGPT2
regulates skeletal myoblast survival and differentiation, we over-
expressed human ANGPT2 in human skeletal myoblasts using
adenoviruses (Ad-ANGPT2) and compared mRNA expression
profiles of these cells to those infected with control adenoviruses
(Ad-GFP). Sub-confluent human myoblasts were maintained for
6 h in SkBM culture medium containing 250 MOI (multiplicity of
infection) of Ad-ANGPT2 (n=6) or Ad-GFP (n=6). Cells were
then washed and maintained for 48 h in SkBM culture medium
containing 15% FBS. After this recovery period, the culture
medium was changed to SkBM culture medium containing 5%
FBS. Cells were collected 12 h later and total RNA was extracted
as described above.
Illumina microarrays. Total RNA (100 ng) was amplified
using the Illumina RNA Amplification kit (Illumina Inc., San
Diego CA) and labelled by incorporation of biotin-16-UTP.
Samples were hybridized to Sentrix Genome-Wide Expression
BeadArray
TM (Illumina Inc.). These arrays use beads containing
50-mer gene-specific probes (a total of 46,000 probes per array).
Arrays were scanned with an Illumina BeadArray Reader
(Montreal Genome Centre, Montreal, Canada) and data
processing and normalization were performed using Illumina
Bead-Studio software. Signal values were normalized by global
mean and log transformed using GeneSifter software (VizX Labs,
Seattle, WA, USA). Pairwise comparisons and ANOVA were
subsequently performed using FlexArray 1.1.3 sofware package
(Genome Quebec, Montreal, Quebec, Canada) and a difference of
at least two-fold with a P-value of less than 0.05 was considered as
a statistically significant change in gene expression. All data is
MIAME compliant and the raw data has been deposited in a
MIAME compliant database (GEO). To investigate gene networks
regulated by ANGPT2 in cultured human skeletal myoblasts, we
analyzed the microarray results using Ingenuity Pathway Analysis
which is a web-based bioinformatics tool (IPA, http://www.
ingenuity.com) based on .1.7 Million published articles. IPA is a
knowledge database generated from the peer-reviewed scientific
publications that enables discovery of biological networks in gene
expression data, determining the functions most significant to
those networks. Gene name identifiers or Ingenuity probe set ID’s
were uploaded into IPA and queried against all other genes stored
in the IPA knowledge database. Each Ingenuity probe set ID was
mapped to its corresponding gene identifier in the IPA knowledge
database. Probe sets representing genes having direct interactions
with genes in the IPA knowledge database are called ‘‘focus’’
genes, which were then used as a starting point for generating
functional networks. Each generated network is assigned a score
according to the number of differentially regulated focus genes in
our array dataset. These scores are derived from negative
Figure 1. Regulation of ANGPT2 expression in myoblasts. A: mRNA expression of ANGPT2 in human skeletal myoblasts (day 0) and after 1, 3,
5 and 7 days of differentiation into myotubes. Values are means 6 SE. *P,0.05 compared with day 0. B: ANGPT2 mRNA expression in human skeletal
myoblasts exposed for 24 h to IL1b, TNFa, IL6, a combination of the three, or H2O2.N=6 .* P ,0.05 compared with control. C: ANGPT2 protein levels
in the media of human skeletal myoblasts exposed for 24 h to BSA (control, C), TNFa or H2O2.N=6 .* P ,0.05 compared with control. D: ANGPT2
protein levels in the media of human umbilical vein endothelial cells (HUVECs) exposed for 24 h to PBS (control, C), TNFa or H2O2.N=6 .* P ,0.05
compared with control.
doi:10.1371/journal.pone.0022882.g001
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found together in a network due to random chance. Scores of 14
or higher have 99.9% confidence level of significance. In reporting
our findings we list networks with a substantially higher confidence
limit and thus represent strong evidence for a given biological
pathway being regulated by ANGPT2 in human skeletal
myoblasts. It should be noted however that while the database
extends the interpretation beyond mRNA transcript levels (as
network genes don’t have to be differentially expressed at the
mRNA level) the database is finite and reflects current knowledge.
To confirm the results obtained with the microarrays, we
performed real-time PCR to evaluate the expression of four genes
which were found to be upregulated (TEL2 and LEP) and
downregulated (CSF3, ANGPTL4 and CTGF) in cells infected
with Ad-ANGPT2 compared to cells infected with Ad-GFP. Real-
time PCR was performed as described above using primers listed
in Supporting Information S1. Relative quantification of TEL2,
LEP, CSF3, ANGPTL4 and CTGF mRNA levels in cells infected
with Ad-ANGPT2 compared to cells infected with Ad-GFP was
determined using the threshold cycle (DDCT) method. In addition,
we verified enhanced leptin production in muscle cells by directly
measuring leptin levels in the culture medium. Sub-confluent
human myoblasts were maintained for 6 h in SkBM culture
medium containing 250 MOI (multiplicity of infection) of Ad-
ANGPT2 (n=6) or Ad-GFP (n=6). Cells were then washed and
maintained for 72 h in SkBM culture medium containing 5%
FBS. The levels of secreted leptin in the culture medium were
measured with a commercial leptin ELISA kit from R&D Systems.
Pathways regulated by ANGPT2. Data were analyzed
using the IPA (IngenuityH Systems, www.ingenuity.com). A data
set containing gene identifiers and corresponding expression
values was uploaded into the application. Each gene identifier
was mapped to its corresponding gene object. A fold-change cutoff
of 2 for both up- and down-regulation and a p-value cutoff of 0.05
were set to identify the genes to be analyzed. These genes, called
focus molecules, were overlaid onto a global molecular network
developed from information in the IPA. Networks of these focus
molecules were then algorithmically generated based on their
connectivity. The functional analysis of a network identified the
biological functions and/or diseases that were most significant to
the genes in the network. Genes and gene products are
represented as nodes, and the biological relationship between
two nodes is represented as an edge (line). All edges are supported
by at least one reference from the literature, textbook or canonical
Figure 2. Regulation of myoblast proliferation, migration and survival by ANGPT2. A: Cell number of human skeletal myoblasts exposed
to PBS (control) or ANGPT2. Cells maintained for 72 in culture medium. N=6. B: Representative Photographs of wound healing assays in human
skeletal myoblasts. Arrows indicate margins of wounds. C: Wound healing intensity in myoblasts exposed to PBS (control) or ANGPT2. N=6 per
group. D: Cytotoxicity and caspase 3/7 activity in human skeletal myoblasts maintained for 36 h in media containing 15%FBS, 0%FBS or 0%FBS +
ANGPT2. N=8 per group. *P,0.05 compared with 15% FBS,
#P,0.05 compared with 0% FBS.
doi:10.1371/journal.pone.0022882.g002
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a gene are stored as separate objects in the IPKB, but are
represented as a single node in the network. The node color
indicates the degree of up- (red) or down- (green) regulation.
Nodes are displayed using various shapes that represent the
functional class of the gene product. It should be emphasized that
one round of analyses were performed with the Ingenuity Pathway
Analysis system considering both up- and downregulated genes in
cells infected with Ad-ANGPT2 compared with cells infected with
Ad-GFP.
Statistical analyses
Results are expressed as means 6SE in all figures. Differences in
terms of cell proliferation, migration, cell death, caspase 3/7
activity, and muscle-specific gene mRNA levels during the
differentiation protocols were detected with Analysis of Variance
with a Bonferroni-type adjustment. Values of P,5% were
considered significant.
Results
ANGPT2 expression in skeletal and endothelial cells
In primary human myoblasts ANGPT2 mRNA levels are
detectable at an abundance of 0.2460.04 copies/10
3 copies of
18S. Those values are similar to those detected in murine skeletal
myoblasts (0.2560.03 copies/10
3 copies of 18S). Expression of
ANGPT2 mRNA in human myoblasts is significantly induced
when they differentiate into myotubes, indicating that mature
Figure 3. ANGPT2 signaling in skeletal myoblasts. A: Representative immunoblots and optical densities of total and phosphorylated AKT and
ERK1/2 proteins in human skeletal myoblasts exposed for 15 min to increasing concentrations of ANGPT2. N=4 per group. B: Representative
immunoblots and optical densities of total and phosphorylated AKT and ERK1/2 proteins in human skeletal myoblasts exposed to 600 ng/ml ANGPT2
for increasing durations. N=4 per group. C–D: Cytotoxicity and caspase 3/7 activity in human skeletal myoblasts maintained for 36 h in media
containing 0%FBS (control) or 0%FBS + ANGPT2 in the presence of PD184352, (PD, ERK1/2 inhibitor), wortmannin, (WM, PI3 kinase inhibitor) and API2
(AKT inhibitor). *P,0.05 compared with control.
doi:10.1371/journal.pone.0022882.g003
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precursors (Figure 1A). Figure 1B indicates that ANGPT2 mRNA
levels in human myoblasts were significantly reduced by IL1b,
significantly augmented by H2O2 whereas TNFa and IL6 had no
effects. Lack of TNFa effect on ANGPT2 production and
upregulation of this production by H2O2 were verified by
measuring ANGPT2 protein levels in the media of human
myoblasts and human umbilical vein endothelial cells (Figure 1C
and D).
Regulation of myoblast myogenesis by ANGPT2
To evaluate the functional significance of increased ANGPT2
expression on muscle fiber regeneration, we measured the effects
of exogenous ANGPT2 on proliferation, migration, differentiation
and survival of human skeletal myoblasts. ANGPT2 has no effect
on myoblast proliferation and migration (Figure 2A–C). However,
ANGPT2 significantly reduces cytotoxicity and capase-3/7
activity in skeletal myoblasts exposed to complete serum
withdrawal, indicating that ANGPT2 promotes myoblast survival
(Figure 2D). To investigate the signaling pathways through which
ANGPT2 promotes myoblast survival, we evaluated the effects of
ANGPT2 on activation of two important pro-survival pathways
(PI3 kinase/AKT and ERK1/2). ANGPT2 elicited transient and
dose-dependent increases in AKT phosphorylation on Thre
308
(site of PI3 kinase mediated phosphorylation) and ERK1/2
phosphorylation on Thre
202/Tyr
204 (site of ERK1/2 mediated
phosphorylation (Figure 3A and B). The importance of the PI3
kinase/AKT and ERK1/2 pathways in the pro-survival effects of
ANGPT2 was assessed using selective pharmacological inhibitors
of these pathways. The inhibitory effects of ANGPT2 on serum
deprivation-induced cytotoxicity and caspase 3/7 activity are
completely eliminated in the presence of selective inhibitors of PI3
kinase, AKT and Erk1/2 (Figure 3C and D). It should be noted
that these inhibitors by themselves had no significant effects on
cytotoxicity and caspase 3/7 activity. Our results suggest that
ANGPT2 promotes myoblast survival and inhibits apoptosis in
these cells through the PI3 kinase/AKT and Erk1/2 pathways.
Figure 4 shows the influence of ANGPT2 on differentiation of
human skeletal myoblasts. Significant inductions of MyoD and
Myogenin occur in control adenovirus (Ad-GFP) transfected cells
incubated for 1 day in differentiation medium; Creatine Kinase
and Myosin Heavy Chain expressions are significantly induced
after 3 and 5 days of incubation, respectively (Figure 4). In
myoblasts transfected with Ad-ANGPT2, even greater levels of
differentiation take place, as indicated by the earlier and
significantly higher expression levels of MyoD, Myogenin,
Creatine Kinase and Myosin Heavy Chain genes, as compared
to cells infected with Ad-GFP (Figure 4).
Mechanisms of ANGPT2 action in skeletal myoblasts
The transcriptomes of human skeletal myoblasts infected with
adenoviruses expressing GFP (control) and ANGPT2 were compared
using Illumina microarrays which revealed that expressions of 45
genes were significantly upregulated by ANGPT2 in skeletal
myoblasts (Table 1 and Supporting Information S1). The largest
relative increase was detected in NRP1 (receptor for VEGF family of
proteins) and TELO2 (regulator of cell cycle). ANGPT2 also induced
the expression of several other genes involved in cell signaling,
including LEP (leptin) (Table 1 and Supporting Information S1).
Table 1 and Supporting Information S1 list 95 genes whose
expression is significantly downregulated by ANGPT2. Heat shock
70 kDa proteins, SPANX transcription factors, inducible nitric oxide
Figure 4. Regulation of myoblast differentiation by ANGPT2. mRNA expressions of MyoD, Myogenin, Creatine Kinase and Myosin Heavy
Chain in human skeletal myoblasts infected with Ad-GFP (control) or Ad-ANGPT2 viruses. Cells were collected at the myoblast phase (day 0) and after
1, 3, 5 and 7 days of differentiation into myotubes. N=6 per group. *P,0.05 compared with day 0 (myoblast phase). # P,0.05 compared with cells
infected with Ad-GFP.
doi:10.1371/journal.pone.0022882.g004
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(AP1) transcription factor and colony stimulating factor 3 are the most
strongly inhibited genes. ANGPT2 also inhibited the expression of
IL6, the chemokine CLL26, angiopoietin-like 4, forkhead transcrip-
tion factor FOXF2, connective tissue growth factor (CTGF) and
insulin receptor substrate 4 (Table 1 and Supporting Information S1).
Microarray results were verified by detecting gene expressions
of two upregulated genes (TELO2 and LEP) and three
downregulated genes (CSF3, ANGPTL4 and CTGF) (Figure 5A).
Upregulation of LEP (leptin) mRNA expression in cells infected
with Ad-ANGPT2 is associated with a significant increase in
secreted LEP protein (Figure 5B). Ingenuity Pathway Analysis
software was used to analyze the microarray dataset in the context
of biological pathways. Supporting Information S1 lists the top
networks and top cellular functions that were generated (data
supplement). Seven major networks of ANGPT2 regulated genes
were detected which contained 24, 18, 14, 11, 10, 10, and 9 focus
genes, respectively (Table 2). The top network contains several
highly connected nodes, with IL6 being the most highly connected
(Figure 6). The second top network contains several highly
connected nodes, including two mitogen activated protein kinase
pathways (p38 and SAPK/JNK), inducible nitric oxide synthase
(NOS2), three immune modulators (IL1, IL12 and IFNa) and
NFkB transcription factor (Supporting Information S1). It should
be noted that the majority of the genes identified in the first and
second top networks were downregulated by ANGPT2.
Discussion
The main findings of our study are: 1) ANGPT2 is constitutively
expressed in human and murine primary skeletal myoblasts; 2)
Table 1. Summary of genes whose expression is significantly altered in Ad-ANGPT2-infected myoblasts as compared with cells
infected with Ad-GFP viruses.
Genes induced by ANGPT2 in skeletal myoblasts
Accession Symbol Definition Ad-ANGPT2/ Function
Ad-GFP
NM001024629 NRP1 Neuropilin 1 transcript variant 3 12.9 Angiogenesis
NM016111 TELO2 Telomere maintenance 2 homology 12.0 Cell cycle
NM201414 APP Amyloid beta A4 precursor 8.9 Apoptosis
NM033397 ITPRIP Inositol triphosphate interacting protein 3.2 Signaling
NM032340 C6orf125 Chromosome 6 open reading frame 125 3.1 Carbohydrase transport
NM000230 LEP Leptin 3.1 Signaling
NM182480 COQ6 Coenzyme Q6 homolog 2.9 Electron transport
NM181877 ZSCAN2 Zinc finger and SCAN domain containing 2 2.8 Transcription
NM032645 C10orf33 Chromosome 10 open reading frame 33 2.7 Electron transport
NM032645 RAPSN Receptor-associated protein of synapse 2.6 Proteolysis
NM016401 C11orf73 Chromosome 11 open reading frame 73 2.6 Unknown
NM001011539 LOC44104 Hypothetical LOC441046 2.5 Metabolism
NM199295 APITD1 Apoptosis-induced TAF9-like domain 1 2.5 Transcription
Genes inhibited by ANGPT2 in skeletal myoblasts
NM002155 HSPA6 Heat shock 70 kDA protein 6 0.03 Protein folding
NM178539 FAM19A2 Family with sequence similarity 19 0.05 Signaling
NM001012977 PAP1M Polyadenylate-binding protein 1 0.05 RNA stability
NM005345 HSPA1A Heat shock 70 kDA protein 1A 0.16 Protein folding
NM139016 C20orf198 Chromosome 20 open reading frame 198 0.20 Unknown
NM005346 HSPA1B Heat Shock 70 kDa protein 0.21 Protein folding
NM001002796 MCTP1 Multiple C2 domains, transmembrane 1 0.21 Ca++-mediated signaling
NM005252 FOS FBJ murine osteosarcome oncogene homolog 0.22 Transcription
NM032461 SPANXB1 Spanx family, member B1 0.26 Transcription
NM153292 NOS2A Nitric oxide synthase 2A 0.26 Signaling
NM030926 ITM2C Integral membrane protein 2C 0.26 Unknown
NM013453 SPANXA1 Spanx family member A1 0.27 Transcription
NM000488 SERPINC1 Serine peptidase inhibtor, clade C 0.27 Apoptosis
NM172220 CSF3 Colony stimulating factor 3 0.28 Immune responses
NM018602 DNAJA4 DNAJ (Hsp40) homolog 0.28 Protein folding
NM022661 SPANXC Spanx family member C 0.28 Transcription
NM001005611 EDA Ectodysplasin A 0.29 Immune responses
doi:10.1371/journal.pone.0022882.t001
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differentiation into myotubes; 3) ANGPT2 expression in both,
skeletal myoblasts and endothelial cells is induced by H2O2 but not
by TNFa, IL6 and IL1b; 4) Upregulation of ANGPT2 expression
in skeletal myoblasts is associated with increased myoblast survival
and differentiation. These effects are mediated through activation
of the PI3-kinase/AKT and Erk1/2 pathways and through
selective and distinct changes in overall cellular gene expression
profiles.
Expressions of ANGPT2 in skeletal muscles
Several investigators have described the detection of ANGPT2
mRNA in skeletal muscle samples obtained from animals or
humans [3,22,23]. However, the cellular origin of this expression is
unclear because various cell types such as skeletal muscle fibers,
endothelial, macrophages and nerve fibers present in muscle
biopsies can contribute to total muscle ANGPT2 levels. Our
group, as well as that of Dallabrida et al. [1,3], have suggested that
human and murine skeletal cells do indeed produce ANGPT2. To
evaluate this possibility, primary human and murine skeletal
myoblasts were isolated, purified and assessed for ANGPT2
production during muscle differentiation. Our results clearly
illustrate that ANGPT2 is produced by skeletal myoblasts and
that ANGPT2 production increases substantially upon differenti-
ation into myotubes (Figure 1). Another cell type that may
contribute to whole skeletal muscle ANGPT2 expression is
endothelial cells. Endothelial cells are well-known to produce
higher levels of ANGPT2 than do other cells, and are primarily
regulated by transcriptional activation of ANGPT2 promoter
[5,24], but also due to the fact that ANGPT2 release can be
rapidly achieved from stores inside Weibel-Palade bodies [25].
Previous studies have described linear relationships between
plasma ANGPT2 and TNFa concentrations in humans with
endotoxemia and sepsis [12,26]. These findings raise the possibility
that muscle ANPGT2 expression is regulated by a direct effect of
TNFa on ANGPT2 transcription. Regulation of ANGPT2
expression by TNFa has been studied in endothelial cells with
contradictory results. An initial report by Kim et al. [9] described
significant but transient upregulation of ANGPT2 expression in
HUVECs exposed to TNFa. Subsequent studies [25,27], however,
failed to show any significant effect of TNFa on endothelial
ANGPT2 expression or release. To verify the direct influence of
TNFa on cellular ANGPT2 expression, we exposed both, human
skeletal myoblasts and endothelial cells to TNFa for 24 h and
found no significant changes in ANGPT2 expression in these cells
(Figure 1). These results suggest that TNFa is unlikely to be the
factor responsible for regulating satellite cell ANGPT2 expression.
There is increasing evidence that the production of angiogenesis
factors by a variety of cells including skeletal muscles is under the
control of reactive oxygen species (ROS). Indeed, several reports
have confirmed that VEGF production by kertainocytes, skeletal
myoblasts, endothelial and epithelial cells is stimulated by H2O2
[13,28–30]. To evaluate whether ROS regulate ANGPT2
production in muscle and endothelial cells, we exposed human
skeletal myoblasts and HUVECs to H2O2. Our study indicates
that H2O2 elicits significant inductions of ANGPT2 production
both in human skeletal myoblasts and in endothelial cells
suggesting that both cell types can contribute to enhanced
Figure 5. Gene regulation by ANGPT2 in skeletal myoblasts. A:
Expressions of TELO2, LEP, CSF3, ANGPTL4 and CTGF in human skeletal
myoblasts infected with Ad-ANGPT2 viruses. Values are expressed as
fold changes from those measured in cells infected with Ad-GFP
(control). B: Expression of leptin in human skeletal myoblasts infected
with Ad-GFP (control) and Ad-ANGPT2 viruses. *P,0.05 compared with
Ad-GFP.
doi:10.1371/journal.pone.0022882.g005
Table 2. Summary of the results of Ingenuity Pathway
Analysis of lists of upregulated and downregulated genes in
human skeletal myoblasts infected with Ad-ANGPT2
compared with cells infected with Ad-GFP viruses.
Top Networks
Associated Network Functions Score
Focus
Molecules
Cell cycle, DNA replication,
Recombination and Repair
50 24
Tissue Morphology, Lipid Metabolism,
Small Molecule Biochemistry
35 18
Cardiovascular System Development
and Function, Tissue Development
25 14
Cellular Assembly and Organization 19 11
Cell Morphology, Cellular Development 16 10
Connective Tissue Development and Function 15 10
Cellular Comprise 14 9
Molecular and Cellular Functions
Name # Molecules
Cell Cycle 32
Cell Death 42
Cellular Assembly and Organization 25
DNA Replication, Recombination and Repair 29
Cellular Growth and Proliferation 37
doi:10.1371/journal.pone.0022882.t002
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These results are in agreement with those of Amano et al., who
reported elevated ANGPT2 expression in pericytes exposed to
H2O2 [31]. The mechanisms, however, through which H2O2
induce ANGPT2 expression in skeletal muscles remain specula-
tive. We speculate that H2O2 may activate ETS transcription
factors [32] and that these factors, due to the abundance of their
binding sites on human ANGPT2 promoter, are likely responsible
for ANGPT2 production in both muscle and endothelial cells in
response to oxidative stress [24].
ANGPT2 regulation of myogenesis
The only available information regarding the influence of
ANGPT2 on skeletal muscle is that of Dallabrida et al. [1], who
reported that cultured skeletal satellite cells adhere to ANGPT1
and ANGPT2 proteins; however, whereas ANGPT1 promotes
survival and inhibits apoptosis, ANGPT2 enhances apoptosis. We
report here for the first time, that while ANGPT2 has no effect on
proliferation and migration of skeletal myoblasts, it strongly
promotes myoblast survival and inhibits apoptosis (Figure 2).
ANGPT2 also strongly enhances differentiation of myoblasts into
myotubes, as evidenced by substantial induction of muscle-specific
transcription factors (MyoD and Myogenin) and muscle-specific
proteins (Creatine Kinase and Myosin Heavy Chain) (Figure 4).
Differences between our conclusions and those of Dallabrida
et al. regarding the influence of ANGPT2 on skeletal myoblast
survival may be attributed to methodological differences. Dallab-
rida and colleagues focused their attention on measuring adhesion
Figure 6. Network analysis of ANGPT2-induced changes in myoblast transcriptome. The top network of regulated genes in human
myoblasts infected with Ad-ANGPT2 viruses vs. cells infected with Ad-GFP viruses (control condition). This figure was created with the Ingenuity
Pathway Analysis system. Upregulated genes are shown in red while downregulated genes are shown in green. Color intensity indicates the degree
of change in gene expression. White nodes are genes whose expression was not significantly changed in cells infected with Ad-ANGPT2 viruses vs.
Ad-GFP viruses. Arrows with plain lines indicate direction interactions, and arrows with interrupted lines represent indirect interactions. Top functions
associated with this network include cell cycle, cellular assembly and organization, DNA replication, recombination and repair.
doi:10.1371/journal.pone.0022882.g006
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ANGPT2 or other proteins such as collagens, fibronectin,
vitronectin and laminin. Their approach was based on an earlier
report indicating that ANGPT1 is incorporated into extracellular
matrices of cells [33]. However, it remains unknown whether or
not ANGPT2 protein is actually incorporated into the extracel-
lular matrices of skeletal myoblasts, so we assessed cell survival
using a physiological approach that exposed skeletal myoblasts to
ANGPT2 protein over 36 h.
We used two approaches to evaluate signaling mechanisms
through which ANGPT2 regulates skeletal myoblast survival and
differentiation. First, we measured activation of the PI3 kinase/AKT
andERK1/2pathwaysinmyoblastsexposed toANGPT2. We found
that ANGPT2 transiently and dose-dependently activates AKT and
ERK1/2 phosphorylation and that ANGPT2 has no effect on
starvation-induced cytotoxicity (index of overall cell death) and
caspase 3/7 activation (index of apoptotic cell death) in the presence
of selective inhibitorsof PI3 kinase, AKT and ERK1/2. These results
suggest that the PI3 kinase and ERK1/2 pathways are critical to the
pro-survival and anti-apoptotic effects of ANGPT2 in skeletal muscle
cells. This conclusion mirrors what has already been established in
endothelial cells [34], although it is unclear in the case of skeletal
myoblastswhetherANGPT2pathwayactivationismediatedthrough
phosphorylation of TIE2 receptors, ligation of integrins or both.
The second approach that we used to gain further insight into
the mechanisms through which ANGPT2 modulates skeletal
myoblast differentiation, survival and apoptosis was to compare
the transcriptomes of myoblasts expressing GFP (control) and
those overexpressing ANGPT2. Our results indicate that
ANGPT2 triggers specific changes in the muscle transcriptome
that involve the upregulation of several genes connected to cell
signaling, including the regulation of cell cycle, assembly and
organization, cell growth and proliferation. The protein that is
most strongly-induced by ANGPT2 is NRP1 (neuropilin 1), which
is a transmembrane receptor for semaphorins (mediators of
neuronal guidance) and VEGFA [35]. NRP1 is expressed in
skeletal muscle progenitor cells (myoblasts) and its expression is
augmented during differentiation into myotubes [35]. These
observations, along with the fact that VEGF strongly promotes
skeletal myoblast survival and enhances myogenic differentiation,
suggest that ANGPT2 may regulate myogenesis through augmen-
tation of VEGF signaling. The protein that is second most induced
by ANGPT2 is telomere maintenance 2 (TELO2), which functions
as an S-phase checkpoint protein in the cell cycle and is a key
element in embryonic development [36].
ANGPT2 also significantly induces the expression and release of
leptin from myoblasts, suggesting that the pro-myogenic and pro-
survival effects of ANGPT2 are likely mediated by leptin (figure 5).
Leptin was identified initially as an adipocyte-derived hormone that
regulates food intake through activation of receptors located in the
hypothalamus. However, leptin is now recognized as a multipotent
cytokine with numerous central and peripheral effects. Leptin and
leptin receptor mRNA and proteins have been detected in mature
skeletal muscle fibers and progenitor cells [37]. In muscle cells, leptin
strongly influences metabolism by promoting both, free fatty acid
oxidation and glucose uptake [38]. It also protects muscle cells from
oxidative stress-induced apoptosis and prevents protein breakdown in
C2C12 cultured myotubes [39,40]. These observations suggest that the
influence of ANGPT2 on skeletal muscle survival may be mediated
through secondary release of leptin which can act on muscle cells
through autocrine mechanism.
In addition to the above-described modulators of cell cycle and
metabolism, network analysis of ANGPT2-regulated genes in
muscle cells revealed that ANGPT2 downregulate many pro-
inflammatory mediators including the inducible nitric oxide
synthase, IL6 and members of cellular networks involving IFNa,
IL1, IL12 and AP-1 and NFkB transcription factors (Figure 6 and
Supporting Information S1). These cytokines and transcription
factors are well known positive modulators of catabolism and
muscle wasting. On the basis of these results, we speculate that
ANGPT2 promotes muscle cells survival and differentiation
through upregulation of key regulators of cell cycle, protein
synthesis and metabolism and inhibition of the expression of
mediators of protein degradation and catabolism.
In summary, our study indicates that ANGPT2 is expressed in
primary human and skeletal myoblasts and that this expression is
significantly induced upon differentiation of myoblasts to myo-
tubes. We also found that skeletal ANGPT2 production is
positively regulated by H2O2 and that ANGPT2 triggers
significant increases in survival and differentiation of skeletal
myoblasts. These effects of ANGPT2 are mediated through
coordinated regulation of several modulators of cell survival,
metabolism, protein synthesis and degradation.
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